Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-09-16 Sale |
2024-09-17 5:21 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
37,000 | $36.23 | $1,340,597 | 247,526 (Indirect Direct) |
View |
| 2024-06-21 Sale |
2024-06-21 7:34 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
37,000 | $39.24 | $1,451,835 | 302,371 (Indirect Direct) |
View |
| 2024-03-19 Sale |
2024-03-20 5:18 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
18,681 | $57.18 | $1,068,161 | 337,871 (Indirect Direct) |
View |
| 2023-12-01 Sale |
2023-12-05 4:21 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
24,000 | $61.13 | $1,467,240 | 346,937 (Indirect Direct) |
View |
| 2023-11-17 Sale |
2023-11-21 4:36 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
8,894 | $49.99 | $444,620 | 370,937 (Indirect Direct) |
View |
| 2023-10-17 Sale |
2023-11-21 4:00 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
24,000 | $49 | $1,176,000 | 379,831 (Indirect Direct) |
View |
| 2023-04-03 Sale |
2023-04-05 4:54 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
500 | $74.05 | $37,025 | 403,831 (Indirect Direct) |
View |
| 2023-03-01 Sale |
2023-03-02 4:20 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
500 | $65.33 | $32,665 | 404,331 (Indirect Direct) |
View |
| 2023-02-01 Sale |
2023-02-02 4:15 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
500 | $52.61 | $26,305 | 404,831 (Indirect Direct) |
View |
| 2023-01-03 Sale |
2023-01-05 7:40 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
500 | $50.7 | $25,350 | 405,331 (Indirect Direct) |
View |
| 2022-12-01 Sale |
2022-12-02 4:30 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
500 | $49.93 | $24,965 | 401,964 (Indirect Direct) |
View |
| 2022-11-01 Sale |
2022-11-03 4:28 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
500 | $60.83 | $30,415 | 402,464 (Indirect Direct) |
View |
| 2022-09-08 Sale |
2022-09-08 4:38 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
15,000 | $65 | $975,000 | 402,964 (Indirect Direct) |
View |
| 2022-08-11 Sale |
2022-08-12 4:57 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
30,000 | $65.63 | $1,968,900 | 388,264 (Indirect Direct) |
View |
| 2022-06-27 Sale |
2022-06-29 4:18 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
1,341 | $46.79 | $62,743 | 287,022 (Indirect) |
View |
| 2022-06-23 Sale |
2022-06-24 5:15 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
15,000 | $45 | $675,000 | 285,679 (Indirect) |
View |
| 2021-05-18 Sale |
2021-05-20 4:53 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
162,873 | $52.54 | $8,558,129 | 31,855 (Indirect) |
View |
| 2020-12-14 Sale |
2020-12-15 5:05 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
25,000 | $54.67 | $1,366,713 | 174,728 (Indirect) |
View |
| 2020-12-04 Sale |
2020-12-07 6:58 pm |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
25,000 | $50.59 | $1,264,854 | 199,728 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-01-01 Option Award |
2025-01-03 4:17 pm |
N/A 2032-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
17,466 | $0 | 269,592 (Direct) |
View |
| 2024-09-23 Exercise |
2024-09-24 4:20 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
4,600 | $13.19 | 252,126 (Direct) |
View |
| 2024-09-23 Exercise |
2024-09-24 4:20 pm |
N/A 2028-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
4,600 | $0 | 252,126 (Direct) |
View |
| 2024-06-28 Exercise |
2024-07-01 4:02 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
900 | $13.19 | 307,871 (Direct) |
View |
| 2024-06-28 Exercise |
2024-07-01 4:02 pm |
N/A 2028-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
900 | $0 | 307,871 (Direct) |
View |
| 2024-04-12 Exercise |
2024-04-15 4:09 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
1,500 | $13.19 | 344,871 (Direct) |
View |
| 2024-04-12 Exercise |
2024-04-15 4:09 pm |
N/A 2028-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
1,500 | $0 | 344,871 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:09 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
5,748 | $59.86 | 362,300 (Direct) |
View |
| 2024-01-01 Option Award |
2024-01-02 4:09 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
3,341 | $0 | 362,300 (Direct) |
View |
| 2023-12-14 Exercise |
2023-12-15 4:04 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
6,274 | $13.19 | 360,211 (Direct) |
View |
| 2023-12-14 Exercise |
2023-12-15 4:04 pm |
N/A 2028-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
6,274 | $0 | 360,211 (Direct) |
View |
| 2023-01-01 Option Award |
2023-01-04 5:35 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
11,308 | $0 | 413,272 (Direct) |
View |
| 2022-08-25 Exercise |
2022-08-26 4:06 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
4,306 | $13.19 | 431,238 (Direct) |
View |
| 2022-08-25 Exercise |
2022-08-26 4:06 pm |
N/A 2028-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
4,306 | $0 | 431,238 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-17 5:08 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
25,394 | $14 | 413,658 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-17 5:08 pm |
N/A 2027-11-08 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
25,394 | $0 | 413,658 (Direct) |
View |
| 2022-07-21 Exercise |
2022-07-22 4:01 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
9,606 | $14 | 443,658 (Direct) |
View |
| 2022-07-21 Exercise |
2022-07-22 4:01 pm |
N/A 2027-11-08 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
9,606 | $0 | 443,658 (Direct) |
View |
| 2022-04-22 Exercise |
2022-04-25 9:35 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
20,000 | $14 | 458,658 (Direct) |
View |
| 2022-04-22 Exercise |
2022-04-25 9:35 pm |
N/A 2027-11-08 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
20,000 | $0 | 458,658 (Direct) |
View |
| 2022-01-01 Option Award |
2022-01-04 4:38 pm |
N/A 2029-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
12,784 | $0 | 380,357 (Direct) |
View |
| 2021-09-10 Exercise |
2021-09-13 4:10 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
6,894 | $14 | 454,428 (Direct) |
View |
| 2021-09-10 Exercise |
2021-09-13 4:10 pm |
N/A 2027-11-08 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
6,894 | $0 | 454,428 (Direct) |
View |
| 2021-06-01 Other |
2021-06-02 4:23 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
47,645 | $0 | 424,114 (Indirect) |
View |
| 2021-04-23 Exercise |
2021-04-26 6:00 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
10,000 | $14 | 617,301 (Direct) |
View |
| 2021-04-23 Exercise |
2021-04-26 6:00 pm |
N/A 2027-11-08 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
10,000 | $0 | 617,301 (Direct) |
View |
| 2021-04-16 Exercise |
2021-04-19 7:29 pm |
N/A N/A |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
50,000 | $14 | 617,301 (Direct) |
View |
| 2021-04-16 Exercise |
2021-04-19 7:29 pm |
N/A 2027-11-08 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
50,000 | $0 | 617,301 (Direct) |
View |
| 2021-01-01 Option Award |
2021-01-04 7:19 pm |
N/A 2030-12-31 |
Apellis Pharmaceuticals Inc. | APLS | Dunlop A. Sinclair Director |
27,600 | $0 | 27,600 (Direct) |
View |